Hydrogen-Generating Silicon-Based Agent Improves Fat Graft Survival in Rats

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Inflammation and Oxidative Stress Research

Background:

• Excessive inflammation and oxidative stress negatively impact fat grafting retention rates.
• Hydrogen gas is known to combat oxidative stress and inflammation but poses challenges for sustained administration.
• A novel silicon (Si)-based agent capable of continuous hydrogen generation in vivo was developed.

Purpose of the Study:

• To evaluate the efficacy of a Si-based agent in improving fat grafting outcomes.
• To investigate the synergistic effects of the Si-based agent and adipose-derived stromal cells (ASCs) on fat graft retention.

Main Methods:

• Fat grafting was performed on rats fed a normal diet or a diet supplemented with a Si-based agent.
• The study included groups receiving fat grafting with ASCs and a combination of the Si-based agent and ASCs.
• Outcomes measured included grafted fat retention rates, inflammatory indices, apoptosis, oxidative stress markers, and histological analysis.

Main Results:

• Both the Si-based agent and ASCs significantly reduced inflammation, oxidative stress, and apoptosis in grafted fat.
• Both interventions independently improved long-term retention rates, histological quality, and overall grafted fat quality.
• The combination of the Si-based agent and ASCs demonstrated enhanced improvements in fat graft retention.

Conclusions:

• Oral administration of the hydrogen-generating Si-based agent enhances fat graft retention by mitigating inflammation and oxidative stress.
• The Si-based agent shows potential for expanding hydrogen-based therapies to applications like fat grafting.
• This approach offers a promising strategy for improving the clinical success of fat grafting procedures.